What is the first-line vasopressor for dengue shock after adequate crystalloid resuscitation?

Vasopressor of Choice in Dengue Shock

Norepinephrine is the first-line vasopressor for dengue shock after adequate crystalloid resuscitation has failed to restore hemodynamic stability.

Clinical Approach

While there are no dengue-specific vasopressor guidelines, the management of dengue shock syndrome (DSS) follows established septic shock principles when fluid resuscitation proves inadequate. The Surviving Sepsis Campaign guidelines provide the framework for vasopressor selection in distributive shock states 1, 2.

Initial Fluid Resuscitation

Before initiating vasopressors:

• Administer crystalloids aggressively as first-line therapy 3
• Target adequate tissue perfusion (warm extremities, capillary refill <3 seconds, mental status improvement, urine output >0.5 mL/kg/hr)
• If unresponsive to crystalloids, consider switching to colloids in dengue shock specifically 3
• Monitor closely for pulmonary edema and fluid overload, which may limit further fluid administration 3

Vasopressor Selection Algorithm

When vasopressors become necessary (persistent hypotension despite adequate fluid resuscitation):

1. First-line: Norepinephrine

   • Strong recommendation with moderate quality evidence 1, 2
   • Target mean arterial pressure (MAP) ≥65 mmHg 1
   • Can be safely administered through peripheral 20-gauge or larger IV line 4
   • Specifically mentioned for dengue shock when fluid restriction occurs due to pulmonary edema 3

2. Second-line additions (if MAP target not achieved):

   • Add vasopressin (0.03 units/minute) to reduce norepinephrine requirements 1, 2
   • Or add epinephrine as alternative 1, 2

3. Alternative in resource-limited settings:

   • Dopamine or epinephrine may be considered when norepinephrine is unavailable 5
   • However, dopamine is only recommended in highly selected patients (low arrhythmia risk, relative bradycardia) 1

Critical Caveats

Timing is crucial: The literature on dengue shock emphasizes that vasopressors should only be initiated when:

• Adequate crystalloid/colloid resuscitation has been attempted
• Fluid administration becomes restricted due to complications (pulmonary edema)
• Hemodynamic instability persists despite appropriate volume replacement 3

Avoid these pitfalls:

• Do not use low-dose dopamine for "renal protection" - this is ineffective 1, 2
• Do not use phenylephrine except in specific circumstances (norepinephrine-induced arrhythmias, high cardiac output with low BP, or salvage therapy) 1
• Do not delay vasopressor initiation once fluid resuscitation proves inadequate - early vasopressor use in fluid-refractory shock improves outcomes 4

Monitoring requirements:

• Arterial catheter placement is recommended when vasopressors are needed 1
• Frequent blood pressure and heart rate monitoring is mandatory 5
• Assess for signs of adequate perfusion continuously

Pediatric Considerations

In children with dengue shock, either epinephrine or norepinephrine are reasonable initial choices for fluid-refractory shock 6. Dopamine may be considered if these agents are unavailable, though it is less preferred 6.

The evidence base for dengue-specific vasopressor management remains limited, with most recommendations extrapolated from septic shock guidelines 1, 2. The key principle is aggressive initial fluid resuscitation followed by prompt norepinephrine initiation when fluids alone fail to restore adequate perfusion 3.